Biosynex SA

EPA:ALBIO.PA

2.76 (EUR) • At close November 8, 2024
Bedrijfsnaam Biosynex SA
Symbool ALBIO.PA
Munteenheid EUR
Prijs 2.76
Beurswaarde 29,700,084
Dividendpercentage 0%
52-weken bereik 2.66 - 8.97
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Larry Abensur
Website https://www.biosynex.com

An error occurred while fetching data.

Over Biosynex SA

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as

Vergelijkbare Aandelen

Malin Corporation plc logo

Malin Corporation plc

MLC.IR

5.8 EUR

Median Technologies SA logo

Median Technologies SA

ALMDT.PA

4.105 EUR

Nanobiotix S.A. logo

Nanobiotix S.A.

NANO.PA

3.954 EUR

Genfit S.A. logo

Genfit S.A.

GNFT.PA

4.89 EUR

Innate Pharma S.A. logo

Innate Pharma S.A.

IPH.PA

1.61 EUR

Carmat SA logo

Carmat SA

ALCAR.PA

1.354 EUR

Cellectis S.A. logo

Cellectis S.A.

ALCLS.PA

1.71 EUR

DBV Technologies S.A. logo

DBV Technologies S.A.

DBV.PA

2.136 EUR

MedinCell S.A. logo

MedinCell S.A.

MEDCL.PA

17.94 EUR

Transgene SA logo

Transgene SA

TNG.PA

0.871 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)